Home > General Updates > Report-in of Work Teams’ Conclusions – Team #2 Yaacov Michlin, CEO, Yissum

Report-in of Work Teams’ Conclusions – Team #2 Yaacov Michlin, CEO, Yissum

For the video click here:

This resource is available exclusively for our members.
CIV Membership - Register Free

<< Back to Agenda…

 

Bio

Yaacov Michlin serves as Yissum’s President and Chief Executive Officer since 2009. Mr. Michlin has been leading more than 250 licensing deals and the creation of more than 30 startup companies. Mr. Michlin also led Yissum to the signing of long term collaborations with Roche, P&G , Coca Cola and other multinational companies and also led the creation and capital raising of Yissum’s new holding company Integra, that acts as a VC to fund biotech projects of the Hebrew University. Currently, Mr. Michlin serves as Chairman and board member of a few of Yissum’s leading spin-off companies in the biotech, agriculture and materials fields. He has also served over the past three years as Co-Chairman of the Israeli Tech Transfer Organization. Before joining Yissum, Yaacov Michlin was involved in consulting to pharmaceutical, hi-tech and biomedical companies (including Teva, Bioline, CBI and Brainsway) in various technology commercialization deals, licensing agreements, capital raising, mergers and acquisitions and joint venture collaborations. Mr. Michlin holds a Bachelor of Law and Economics, cum laude, and a Master of Law degree, both from Bar-Ilan University, Israel, and a MBA, cum laude, from the Technion Israel Institute of technology.

Check Also

CIV March 2017 Updates

Members of the Coller Institute of Venture community receive periodic announcements about publications, events, awards, grants, and exclusive membership benefits.
To start receiving announcements, Join our community – Become a member!